Login  |  Register

Pralsetinib in Cancer Treatment: Market Analysis and Forecast to 2034

The global pralsetinib market is driven by rising cancer incidence, particularly non-small cell lung cancer (NSCLC) and thyroid cancers, increasing demand for targeted therapies.